Post-translational modifications of the apelin receptor regulate its functional expression

Post-translational modifications (PTMs) are protein modifications that occur after protein biosynthesis, playing a crucial role in regulating protein function.

They are involved in the functional expression of G-protein-coupled receptors (GPCRs), as well as intracellular and secretory protein signaling.

Here, we aimed to investigate the PTMs of the apelin receptor (APLNR), a GPCR and their potential influence on the receptor's function.

In an in vitro experiment using HEK cells, we only observed glycosylation as a PTM of the APLNR and ineffective receptor signaling by the agonist, (Pyr(1))-apelin-13.

In contrast, when analyzing mouse spinal cord, we detected glycosylation and other PTMs, excluding isopeptidation.

This suggests that additional PTMs are involved in the functional expression of the APLNR in vitro.

In summary, these findings suggest that the APLNR in vivo requires multiple PTMs for functional expression.

To comprehensively understand the pharmacological effects of the APLNR, it is essential to establish an in vitro system that adequately replicates the receptor's PTM profile.

Nonetheless, it is crucial to overcome the challenge of heat-sensitive proteolysis in APLNR studies.

By elucidating the regulation of PTMs, further research has the potential to advance the analysis and pharmacological studies of both the apelin/APLNR system and GPCR signal modulation.